We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Victrex (VCT) Ordinary 1p

Sell:1,283.00p Buy:1,285.00p 0 Change: 12.00p (0.94%)
FTSE 250:0.51%
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,283.00p
Buy:1,285.00p
Change: 12.00p (0.94%)
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,283.00p
Buy:1,285.00p
Change: 12.00p (0.94%)
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.

Contact details

Address:
Victrex Technology Centre
Hillhouse International
THORNTON CLEVELEYS
FY5 4QD
United Kingdom
Telephone:
+44 (01253) 897700
Website:
https://www.victrexplc.com/

Important dates

Future events
Interim results 13 May 2024 13/05/24
Past events
Final dividend payment date 23 February 2024 23/02/24
AGM 09 February 2024 09/02/24
Final ex-dividend date 25 January 2024 25/01/24
Annual report 09 January 2024 09/01/24
Final results 05 December 2023 05/12/23
Interim management statement 06 July 2023 06/07/23
Interim dividend payment date 03 July 2023 03/07/23
Trading Announcement 14 June 2023 14/06/23
Interim ex-dividend date 25 May 2023 25/05/23
Interim results 09 May 2023 09/05/23

General stock information

EPIC:
VCT
ISIN:
GB0009292243
Market cap:
£1.12 billion
Shares in issue:
87.02 million
Sector:
Chemicals
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 250,FTSE 350,FTSE All Share,FTSE 350 Higher Yield

Key personnel

  • Jakob Sigurdsson
    Chief Executive Officer, Executive Director
  • Ian Melling
    Chief Financial Officer, Executive Director
  • Jane Brisley
    General Counsel, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.